ArticleBlood advances2021

FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma.

Austin B Bigley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.